河(he)北(bei)(bei)天(tian)成(cheng)(cheng)藥(yao)(yao)(yao)業(ye)(ye)(ye)股份有(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si)始建(jian)于1970年(nian)(nian),1998年(nian)(nian)由(you)國有(you)企(qi)業(ye)(ye)(ye)改(gai)制(zhi)為有(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si),是(shi)滄州(zhou)市十家改(gai)制(zhi)企(qi)業(ye)(ye)(ye)之一(yi)(yi),也是(shi)一(yi)(yi)家虧損(sun)企(qi)業(ye)(ye)(ye)改(gai)制(zhi)成(cheng)(cheng)功的企(qi)業(ye)(ye)(ye)。2010年(nian)(nian)3月改(gai)制(zhi)為股份有(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si),河(he)北(bei)(bei)天(tian)成(cheng)(cheng)藥(yao)(yao)(yao)業(ye)(ye)(ye)股份有(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si)除(chu)母公(gong)(gong)司(si)(si)(si)以外還下設兩個(ge)公(gong)(gong)司(si)(si)(si),即(ji):“河(he)北(bei)(bei)道(dao)恩藥(yao)(yao)(yao)業(ye)(ye)(ye)有(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si)”,“河(he)北(bei)(bei)天(tian)成(cheng)(cheng)藥(yao)(yao)(yao)業(ye)(ye)(ye)股份有(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si)滄州(zhou)渤海(hai)分公(gong)(gong)司(si)(si)(si)(河(he)北(bei)(bei)諾特藥(yao)(yao)(yao)業(ye)(ye)(ye)有(you)限(xian)(xian)公(gong)(gong)司(si)(si)(si))”,已形成(cheng)(cheng)藥(yao)(yao)(yao)物研發、原料藥(yao)(yao)(yao)、制(zhi)劑全產(chan)業(ye)(ye)(ye)鏈,原料藥(yao)(yao)(yao)企(qi)業(ye)(ye)(ye)坐落在臨港經濟開發區(qu),制(zhi)劑企(qi)業(ye)(ye)(ye)坐落在滄州(zhou)市經濟開發區(qu),是(shi)滄州(zhou)市大型(xing)的綜合(he)性制(zhi)藥(yao)(yao)(yao)企(qi)業(ye)(ye)(ye)。公(gong)(gong)司(si)(si)(si)產(chan)品(pin)暢(chang)銷全國31個(ge)省市及地區(qu),部分產(chan)品(pin)遠銷到東歐、東南亞(ya)、中亞(ya)、南美洲和非洲等30多個(ge)地區(qu)和國家。
目(mu)(mu)前(qian)(qian),公(gong)司現(xian)(xian)有(you)職(zhi)工(gong)1000多人(ren)、擁有(you)碩士研(yan)究生以(yi)上學(xue)歷人(ren)員(yuan)60余人(ren),大(da)學(xue)生350余人(ren),中高級(ji)專(zhuan)業職(zhi)稱(cheng)者230人(ren),專(zhuan)職(zhi)質檢(jian)人(ren)員(yuan)120人(ren)。公(gong)司在高速發(fa)(fa)(fa)(fa)展的(de)(de)(de)同時,一直大(da)力發(fa)(fa)(fa)(fa)展新產(chan)(chan)品(pin)(pin)研(yan)發(fa)(fa)(fa)(fa)工(gong)作。目(mu)(mu)前(qian)(qian)已(yi)經成(cheng)功投(tou)產(chan)(chan)的(de)(de)(de)新藥(yao)(yao)(yao)產(chan)(chan)品(pin)(pin)和國內仿(fang)制(zhi)藥(yao)(yao)(yao)產(chan)(chan)品(pin)(pin)有(you):平衡鹽沖(chong)洗液、木(mu)糖(tang)醇氯化鈉(na)注射(she)液(新藥(yao)(yao)(yao))、α-酮酸(suan)片、阿魏酸(suan)鈉(na)、注射(she)用(yong)轉化糖(tang)、注射(she)用(yong)磷酸(suan)肌(ji)酸(suan)鈉(na)、復方電解質注射(she)液等。目(mu)(mu)前(qian)(qian),公(gong)司已(yi)經開(kai)(kai)發(fa)(fa)(fa)(fa)了新藥(yao)(yao)(yao)品(pin)(pin)種3個(ge)(ge),仿(fang)制(zhi)新藥(yao)(yao)(yao)20多個(ge)(ge),落戶產(chan)(chan)品(pin)(pin)16個(ge)(ge)。2019年,我公(gong)司實(shi)現(xian)(xian)銷售收入近(jin)10億元(yuan),全年研(yan)發(fa)(fa)(fa)(fa)投(tou)入近(jin)3600萬元(yuan)。目(mu)(mu)前(qian)(qian),公(gong)司積極主動地謀求(qiu)以(yi)脂質體抗癌、心腦(nao)血管(guan)、腫瘤、免(mian)疫調節等代謝類(lei)疾病(bing)用(yong)藥(yao)(yao)(yao)為(wei)(wei)開(kai)(kai)發(fa)(fa)(fa)(fa)的(de)(de)(de)方向,發(fa)(fa)(fa)(fa)展多劑型并存(cun),大(da)力發(fa)(fa)(fa)(fa)展無菌水(shui)針(zhen)劑及無菌滴眼液。同時結合水(shui)針(zhen)劑重點產(chan)(chan)品(pin)(pin)開(kai)(kai)發(fa)(fa)(fa)(fa)原料藥(yao)(yao)(yao),實(shi)現(xian)(xian)從原料到制(zhi)劑的(de)(de)(de)產(chan)(chan)業鏈配套生產(chan)(chan),建立起品(pin)(pin)種、技術與品(pin)(pin)牌優勢。努(nu)力提(ti)高現(xian)(xian)有(you)產(chan)(chan)品(pin)(pin)的(de)(de)(de)技術水(shui)平,降低(di)成(cheng)本,同時以(yi)現(xian)(xian)有(you)生產(chan)(chan)設施為(wei)(wei)依托(tuo),以(yi)市(shi)場需求(qiu)為(wei)(wei)導向,積極尋求(qiu)具有(you)比較(jiao)優勢的(de)(de)(de)新產(chan)(chan)品(pin)(pin)。
公(gong)司生產(chan)大(da)(da)容量(liang)(liang)(liang)注(zhu)(zhu)(zhu)射(she)(she)劑(ji)、小容量(liang)(liang)(liang)注(zhu)(zhu)(zhu)射(she)(she)劑(ji)、粉針劑(ji)、片(pian)劑(ji)、顆粒劑(ji)、膠囊(nang)劑(ji)等(deng)六個劑(ji)型近200種產(chan)品(pin)和中藥(yao)(yao)提(ti)取物。我公(gong)司以(yi)大(da)(da)容量(liang)(liang)(liang)注(zhu)(zhu)(zhu)射(she)(she)劑(ji)和小容量(liang)(liang)(liang)注(zhu)(zhu)(zhu)射(she)(she)劑(ji)為(wei)主,做專業的(de)注(zhu)(zhu)(zhu)射(she)(she)劑(ji)藥(yao)(yao)品(pin)生產(chan)商。大(da)(da)容量(liang)(liang)(liang)注(zhu)(zhu)(zhu)射(she)(she)液(ye)產(chan)品(pin)齊(qi)全(quan),多種包裝形式并存,在(zai)PP瓶(ping)、軟(ruan)袋、玻璃(li)瓶(ping)輸液(ye)的(de)基礎上,向(xiang)雙室袋、多室袋等(deng)國際(ji)先進的(de)輸液(ye)包裝形式發展。小容量(liang)(liang)(liang)注(zhu)(zhu)(zhu)射(she)(she)劑(ji)在(zai)玻璃(li)安瓿的(de)基礎上,大(da)(da)力發展塑瓶(ping)(PP和PE)安瓿及西林(lin)瓶(ping)小水針劑(ji)。積(ji)極謀(mou)求國際(ji)高端GMP認證(zheng),由內銷為(wei)主向(xiang)內銷與出口并重(zhong)轉變。